Vortioxetine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 27 USDMF, 3 JDMF, 14 EU WC, 10 KDMF, 9 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers, 18 FDA Orange Book, 62 Europe, 6 Canada, 20 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 2 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 2 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 17 Direct Compression, 17 Disintegrants & Superdisintegrants, 14 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Granulation, 9 Co-Processed Excipients, 8 Coating Systems & Additives, 5 Parenteral, 4 Film Formers & Plasticizers, 3 Controlled & Modified Release, 2 Topical, 2 Coloring Agents, 2 Rheology Modifiers, 1 Solubilizers, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents